Treatment of MDR-TB: is hepatotoxicity a problem?
Int J Tuberc Lung Dis
.
2012 May;16(5):571.
doi: 10.5588/ijtld.12.0199.
Authors
Robert Loddenkemper
,
Tom Schaberg
PMID:
22507929
DOI:
10.5588/ijtld.12.0199
No abstract available
Publication types
Editorial
Comment
MeSH terms
Antitubercular Agents / adverse effects*
Chemical and Drug Induced Liver Injury / etiology*
Female
Humans
Male
Tuberculosis, Multidrug-Resistant / drug therapy*
Substances
Antitubercular Agents